Low Circulating Adropin Concentrations with Obesity and Aging Correlate with Risk Factors for Metabolic Disease and Increase after Gastric Bypass Surgery in Humans | Zendy

Andrew A. Butler | Zendy; Charmaine S. Tam | Zendy; Kimber L. Stanhope | Zendy; Bruce M. Wolfe | Zendy; Mohamed R. Ali | Zendy; Majella O’Keeffe | Zendy; MariePierre StOnge | Zendy; Éric Ravussin | Zendy; Peter J. Havel | Zendy

Open Access

Low Circulating Adropin Concentrations with Obesity and Aging Correlate with Risk Factors for Metabolic Disease and Increase after Gastric Bypass Surgery in Humans

Author(s) -

Andrew A. Butler,

Charmaine S. Tam,

Kimber L. Stanhope,

Bruce M. Wolfe,

Mohamed R. Ali,

Majella O’Keeffe,

MariePierre StOnge,

Éric Ravussin,

Peter J. Havel

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-2194

Subject(s) - medicine , insulin resistance , endocrinology , obesity , body mass index , overweight , confidence interval , gastric bypass surgery , weight loss , gastric bypass

Mouse studies suggest that adropin, a peptide hormone, is required for metabolic homeostasis and prevention of obesity-associated insulin resistance. Whether obesity and insulin resistance are associated with low plasma adropin levels in humans is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research